Yijun Zhang

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Author Correction: Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

Author Correction: Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

Journal: Nature cancer

Published: July 16, 2026

DTX3 promotes anti-tumor immunity by inducing PD-L1 ubiquitination and is suppressed by p65/miR-222 in bladder cancer.

DTX3 promotes anti-tumor immunity by inducing PD-L1 ubiquitination and is suppressed by p65/miR-222 in bladder cancer.

Journal: Oncogene

Published: April 15, 2026

Primary renal synovial sarcoma: a clinicopathological study of 23 cases highlighting the diagnostic value of SS18-SSX, TLE1, and INI1 immunohistochemistry panel.

Primary renal synovial sarcoma: a clinicopathological study of 23 cases highlighting the diagnostic value of SS18-SSX, TLE1, and INI1 immunohistochemistry panel.

Journal: Virchows Archiv : an international journal of pathology

Published: March 16, 2026

RNF19A facilitates gastric cancer progression by regulating the Hippo/YAP axis.

RNF19A facilitates gastric cancer progression by regulating the Hippo/YAP axis.

Journal: International immunopharmacology

Published: May 15, 2025

RC48-ADC monotherapy or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma with HER2 low and null expression: a multicenter, real-world, retrospective study.

RC48-ADC monotherapy or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma with HER2 low and null expression: a multicenter, real-world, retrospective study.

Journal: BMC cancer

Published: February 05, 2025

DTX3 suppresses bladder cancer cell invasion and metastasis by inhibiting the Notch signaling pathway.

DTX3 suppresses bladder cancer cell invasion and metastasis by inhibiting the Notch signaling pathway.

Journal: International immunopharmacology

Published: October 10, 2024

Adenocarcinoma of the rete testis: clinicopathological study of 18 cases with emphasis on MET amplification and a review of the literature.

Adenocarcinoma of the rete testis: clinicopathological study of 18 cases with emphasis on MET amplification and a review of the literature.

Journal: Histopathology

Published: August 06, 2024

First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective Study.

First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: July 19, 2024

Primary adenocarcinoma of the spermatic cord: a case report and review of the literature.

Primary adenocarcinoma of the spermatic cord: a case report and review of the literature.

Journal: Diagnostic pathology

Published: May 10, 2024

Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy.

Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy.

Journal: International urology and nephrology

Published: April 05, 2023

Perivesical Fat Invasive Pattern as Prognostic Factor and Predictor of Response to Adjuvant Chemotherapy in T3 Stage Bladder Cancer.

Perivesical Fat Invasive Pattern as Prognostic Factor and Predictor of Response to Adjuvant Chemotherapy in T3 Stage Bladder Cancer.

Journal: Clinical genitourinary cancer

Published: December 04, 2022

Cutoff values of PD-L1 expression in urinary cytology samples for predicting response to immune checkpoint inhibitor therapy in upper urinary tract urothelial carcinoma.

Cutoff values of PD-L1 expression in urinary cytology samples for predicting response to immune checkpoint inhibitor therapy in upper urinary tract urothelial carcinoma.

Journal: Cancer cytopathology

Published: July 12, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026